Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia

NCT00003174 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: bryostatin 1
DRUG: cladribine

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]